KRS 205.5365: Prohibition on expenditure of Medicaid funds for cross -sex hormones for

treatment of gender dysphoria or gender reassignment surgery.

Notwithstanding any provision of law to the contrary and unless required under federal

law, the Department for Medicaid Services and any managed care organization with

whom the department contracts for the delivery of Medicaid services are hereby

prohibited from expending any Medicaid funds on any of the following:

(1) Cross-sex hormones when prescribed or admi nistered primarily or solely for the

treatment of gender dysphoria; and

(2) Gender reassignment surgery to alter or remove physical or anatomical

characteristics or features that are typical for and characteristic of a person's

biological sex.